Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;46(11):3636-8.
doi: 10.1128/JCM.01308-08. Epub 2008 Sep 3.

Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis

Affiliations

Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis

Philippe Bidet et al. J Clin Microbiol. 2008 Nov.

Abstract

We used real-time PCR to examine the persistence of Bordetella pertussis DNA in serial nasopharyngeal aspirates from 22 children treated for pertussis. After 5 days of treatment, PCR was positive for all 21 assessable patients. After 14 and 21 days, PCR was still positive for 83% (10/12) and 66% (4/6) of assessable patients, respectively. One patient was tested 1 month after treatment initiation, and B. pertussis DNA was still detectable. Quantitative analysis showed that the DNA concentration diminished during treatment in all except one case. The PCR cycle threshold at which B. pertussis DNA became detectable increased by a mean of 1.7 cycles per day (range, 0.86 to 3.68 cycles per day). Real-time PCR can thus be used to diagnose pertussis in young children for up to 3 weeks after treatment initiation. Its potential value for assessing the treatment outcome remains to be determined.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Time course of IS481 real-time PCR CT values applied to serial nasopharyngeal samples from 18 infants treated for pertussis.

References

    1. Baron, S., E. Njamkepo, E. Grimprel, P. Begue, J. C. Desenclos, J. Drucker, and N. Guiso. 1998. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. 17412-418. - PubMed
    1. Bartkus, J. M., B. A. Juni, K. Ehresmann, C. A. Miller, G. N. Sanden, P. K. Cassiday, M. Saubolle, B. Lee, J. Long, A. R. Harrison, Jr., and J. M. Besser. 2003. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J. Clin. Microbiol. 411167-1172. - PMC - PubMed
    1. Bonacorsi, S., C. Farnoux, P. Bidet, V. Caro, S. Aizenfisz, M. Benhayoun, Y. Aujard, N. Guiso, and E. Bingen. 2006. Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate. J. Clin. Microbiol. 443830-3832. - PMC - PubMed
    1. Edelman, K., S. Nikkari, O. Ruuskanen, Q. He, M. Viljanen, and J. Mertsola. 1996. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr. Infect. Dis. J. 1554-57. - PubMed
    1. Floret, D. 2001. Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units. Arch. Pediatr. 8(Suppl. 4)705s-711s. - PubMed